Drug search by name

Orphenadrine Extended-Release Tablets and Anticholinergic effects

Generic Name: orphenadrine
Dosage Forms: n.a.
Other Brand Names: Norflex , Banflex, Orphenate , Flexoject, Flexon, Mio-Rel , Myolin, Orfro , Norflex Injectable, Antiflex

Result of checking the interaction of drug Orphenadrine Extended-Release Tablets and disease Anticholinergic effects for safety when used together.

Check result:

Orphenadrine Extended-Release Tablets <> Anticholinergic effects

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Orphenadrine has mild anticholinergic activity, to which elderly patients are particularly sensitive. The manufacturer considers the use of orphenadrine to be contraindicated in patients with glaucoma, pyloric or duodenal obstruction, achalasia, prostatic hypertrophy, bladder neck obstruction, or myasthenia gravis. Orphenadrine should be used cautiously in other conditions that are likely to be exacerbated by anticholinergic activity, such as urinary retention and gastrointestinal obstructive disorders.

References: